Rapid drug market shifts create new risks and challenge Europe’s preparedness

Rapid shifts in Europe's drug market are creating new health and security risks and challenging the region's capacity to respond. This warning comes from the European Union Drugs Agency (EUDA) in its European Drug Report 2025: Trends and Developments, released today (1). Based on data from 29 countries (EU-27, Norway and Türkiye), this annual review highlights latest trends and emerging threats. Now in its 30th edition, the report provides evidence to inform drug policy and practice. It shows how Europe's drug market continues to evolve, with both suppliers and consumers adapting to…